Diagnosis & staging of lymphoma explained

Thank you for joining us for Nurse Learning Module 2.  
We hope you enjoyed the session and will join us again for our upcoming Nurse Learning Modules. 

You can also email us at nurse@lymphoma.org.au

The first section is a short assessment to ensure we met our objectives of the Nurse Learning Module.  We value your feedback and comments to ensure that we can continue to provide relevant and useful lymphoma/CLL education and updates.

Question Title

1. Which is the LEAST effective type of lymph node biopsy for the diagnosis of lymphoma? (Required.)

Question Title

2. Flow cytometry is a technique used for immunophenotyping (Required.)

Question Title

3. Immunophenotyping is a process used to distinguish between normal lymphocytes and lymphoma cells (Required.)

Question Title

4. Immunophenotyping: (Required.)

Question Title

5. A lymphoma cell that expresses CD20 will indicate that it is a T-cell. (Required.)

Question Title

6. A PET scan: (Required.)

Question Title

7. A PET scan can be used for the following reasons: (Required.)

Question Title

8. Some poor prognostic factors for people diagnosed with aggressive NHL are (select all that apply) (Required.)

Question Title

9. When a patient is described to have B-symptoms, what symptoms do they have? (Required.)

Question Title

10. Using the Ann Arbour & Lugano staging system, a patient who has been diagnosed with Hodgkin lymphoma, has disease in 2 sites above the diaphragm, enlarged nodes in the cervical area and a mediastinal mass is 9cm in size.  The patient presented with night sweats & fevers and some loss of weight (around 3kg).  What stage would they be classified as?

Question Title

11. Full name (Required.)

Question Title

12. Email address (Required.)

0 of 12 answered
 

T